Investor Presentation Q1 2023
116
Investor presentation
First three months of 2023
Insulin market size and volume share of growth and
market share in Region China
Total
Insulin market share and market size (DKK billion)
53%
Long-
acting
27%
4
Fast-
acting
76% 2
Premix
86%
3
32%
Human
2
Novo Nordisk
Competitors
Region China
Market
growth
A Market
share
Insulin volume: market share
80%
50%
11
-26.1%
+2.9%
40%
60%
46%
30%
-36.4%
+2.4%
40%
20%
20%
9%
10%
-19.1%
-4.4%
0%
-1% 0%
-3%
-19.3%
+5.6%
-20%
Feb
2020
-NN market share
-10%
Feb
2023
-18.2%
-6.1%
Source: IQVIA, Feb 2023, LHS graph - Value, RHS Graph - Volume, MAT; NN: Novo Nordisk; Region China covers Mainland China, Taiwan, and Hong Kong
NN share of growth
-Market growth (right axis)
NN growth (right axis)View entire presentation